Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level.

Numerical differences in favor of IXEQ4W versus placebo were observed in the elevated CRP subgroup, but these did not reach statistical significance (Fig. 4 A).

also in 111,027 other papers